Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Shareholder Equity 2009–2025
Harvard Bioscience, Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Harvard Bioscience, Inc. shareholder equity as of December 31, 2025: 13.7M, a 78.32% decrease year-over-year.
- Harvard Bioscience, Inc. shareholder equity for 2025 were 13.7M, a 78.32% decrease from 2024.
- Harvard Bioscience, Inc. shareholder equity for 2024 were 63.3M, a 13.32% decrease from 2023.
- Harvard Bioscience, Inc. shareholder equity for 2023 were 73.1M, a 1.18% increase from 2022.
- Harvard Bioscience, Inc. shareholder equity for 2022 were 72.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Harvard Bioscience, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $63 |
| 2023 | $73 |
| 2022 | $72 |
| 2021 | $83 |
| 2020 | $77 |
| 2019 | $82 |
| 2018 | $83 |
| 2017 | $81 |
| 2016 | $72 |
| 2015 | $78 |
| 2014 | $95 |
| 2013 | $94 |
| 2012 | $104 |
| 2011 | $95 |
Harvard Bioscience, Inc. Shareholder Equity — FAQ
Harvard Bioscience, Inc. (HBIO) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HBIO's shareholder equity history?
The chart and table above show Harvard Bioscience, Inc.'s shareholder equity by year and by quarter, including the growth rate.